Month: March 2015

• March 26, 2015
• Imaging & mpMRI

Experts Weigh In On MRI and Active Surveillance

An international team of experts on imaging prostate cancer participated in a review of the literature on prostate MRI and active surveillance.[i] To give you an idea of how impressive the team was, here is a list of the institutions they represent: Erasmus University Medical Center (Depts. of Urology and Radiology), Rotterday, the Netherlands University keep reading

• March 22, 2015
• General Prostate Information

Scan Abuse and How to Avoid It

  Sadly, prostate cancer (PCa) patients with low-risk disease are still being sent for needless diagnostic bone and CT scans. This was the finding of an impressive multi-disciplinary research team from several institutions (U.S. Veterans Administration and various medical and public policy departments within New York University and Yale University). The investigators found that nearly keep reading

• March 5, 2015
• Other Treatments

Put an End to Overtreatment

“There is increased use of radiotherapy among patients with indolent prostate cancer with limited to no correlation with tumor biology.” This conclusion was reached by a research team out of UCLA after studying the treatment choices of 37,621 patients.[i] In fact, over half (57.9%) of the men were sent for radiation, while 19.1% had a keep reading

• March 1, 2015
• Biopsy
• Imaging & mpMRI

Let’s Put An End To Unnecessary Repeat Biopsies

It’s always affirming to find peer-reviewed data that confirms my professional experience, convictions, and commitment to patients. A newly published study based on over 1800 men reveals some hard facts about the incidence of repeat biopsies, and how unproductive they often are. The study is out of New York University (NYU).[i] The authors reviewed the keep reading